View Cart  

Mylan to Sell Generic Orapred in 2014, Expects First-Filer Exclusivity

A A
Mylan can begin selling a generic version of Shionogi Pharma’s lung drug Orapred ODT in April 2014 or earlier under certain circumstances per an agreement with the brand drug’s maker.

To View This Article:

Login

Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00